German Multicenter Study Investigating Lu 177-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

Kambiz Rahbar; Hojjat Ahmadzadehfar; Clemens Kratochwil; Uwe Haberkorn; Michael Schaefers; Markus Essler; Richard P. Baum; Harshad R. Kulkarni; Matthias Schmidt; Alexander Drzezga; Peter Bartenstein; Andreas Pfestroff; Markus Luster; Ulf Luetzen; Marlies Marx; Vikas Prasad; Winfried Brenner; Alexander Heinzel; Felix M. Mottaghy; Juri Ruf; Philipp Tobias Meyer; Martin Heuschkel; Maria Eveslage; Martin Boegemann; Wolfgang Peter Fendler; Bernd Joachim Krause

doi:10.2967/jnumed.116.183194

German Multicenter Study Investigating Lu ¹⁷⁷-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

Kambiz Rahbar^*, Hojjat Ahmadzadehfar, Clemens Kratochwil, Uwe Haberkorn, Michael Schaefers, Markus Essler, Richard P. Baum, Harshad R. Kulkarni, Matthias Schmidt, Alexander Drzezga, Peter Bartenstein, Andreas Pfestroff, Markus Luster, Ulf Luetzen, Marlies Marx, Vikas Prasad, Winfried Brenner, Alexander Heinzel, Felix M. Mottaghy, Juri RufPhilipp Tobias Meyer, Martin Heuschkel, Maria Eveslage, Martin Boegemann, Wolfgang Peter Fendler, Bernd Joachim Krause

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	85-90
Number of pages	6
Journal	Journal of Nuclear Medicine
Volume	58
Issue number	1
DOIs	https://doi.org/10.2967/jnumed.116.183194
Publication status	Published - Jan 2017

Keywords

prostate cancer
PSMA-617
mCRPC
radioligand therapy
GA-68-PSMA LIGAND
CLINICAL-TRIALS
PSMA
ENZALUTAMIDE
ABIRATERONE
STATISTICS
DOCETAXEL
PET/CT

Access to Document

10.2967/jnumed.116.183194

Cite this

Rahbar, K., Ahmadzadehfar, H., Kratochwil, C., Haberkorn, U., Schaefers, M., Essler, M., Baum, R. P., Kulkarni, H. R., Schmidt, M., Drzezga, A., Bartenstein, P., Pfestroff, A., Luster, M., Luetzen, U., Marx, M., Prasad, V., Brenner, W., Heinzel, A., Mottaghy, F. M., ... Krause, B. J. (2017). German Multicenter Study Investigating Lu ¹⁷⁷-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients. Journal of Nuclear Medicine, 58(1), 85-90. https://doi.org/10.2967/jnumed.116.183194

Rahbar, Kambiz ; Ahmadzadehfar, Hojjat ; Kratochwil, Clemens ; Haberkorn, Uwe ; Schaefers, Michael ; Essler, Markus ; Baum, Richard P. ; Kulkarni, Harshad R. ; Schmidt, Matthias ; Drzezga, Alexander ; Bartenstein, Peter ; Pfestroff, Andreas ; Luster, Markus ; Luetzen, Ulf ; Marx, Marlies ; Prasad, Vikas ; Brenner, Winfried ; Heinzel, Alexander ; Mottaghy, Felix M. ; Ruf, Juri ; Meyer, Philipp Tobias ; Heuschkel, Martin ; Eveslage, Maria ; Boegemann, Martin ; Fendler, Wolfgang Peter ; Krause, Bernd Joachim. / German Multicenter Study Investigating Lu ¹⁷⁷-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients. In: Journal of Nuclear Medicine. 2017 ; Vol. 58, No. 1. pp. 85-90.

@article{09d8d730ea2549ef8853990467650aa2,

title = "German Multicenter Study Investigating Lu 177-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients",

keywords = "prostate cancer, PSMA-617, mCRPC, radioligand therapy, GA-68-PSMA LIGAND, CLINICAL-TRIALS, PSMA, ENZALUTAMIDE, ABIRATERONE, STATISTICS, DOCETAXEL, PET/CT",

author = "Kambiz Rahbar and Hojjat Ahmadzadehfar and Clemens Kratochwil and Uwe Haberkorn and Michael Schaefers and Markus Essler and Baum, {Richard P.} and Kulkarni, {Harshad R.} and Matthias Schmidt and Alexander Drzezga and Peter Bartenstein and Andreas Pfestroff and Markus Luster and Ulf Luetzen and Marlies Marx and Vikas Prasad and Winfried Brenner and Alexander Heinzel and Mottaghy, {Felix M.} and Juri Ruf and Meyer, {Philipp Tobias} and Martin Heuschkel and Maria Eveslage and Martin Boegemann and Fendler, {Wolfgang Peter} and Krause, {Bernd Joachim}",

year = "2017",

month = jan,

doi = "10.2967/jnumed.116.183194",

language = "English",

volume = "58",

pages = "85--90",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine and Molecular Imaging",

number = "1",

}

Rahbar, K, Ahmadzadehfar, H, Kratochwil, C, Haberkorn, U, Schaefers, M, Essler, M, Baum, RP, Kulkarni, HR, Schmidt, M, Drzezga, A, Bartenstein, P, Pfestroff, A, Luster, M, Luetzen, U, Marx, M, Prasad, V, Brenner, W, Heinzel, A, Mottaghy, FM, Ruf, J, Meyer, PT, Heuschkel, M, Eveslage, M, Boegemann, M, Fendler, WP & Krause, BJ 2017, 'German Multicenter Study Investigating Lu ¹⁷⁷-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients', Journal of Nuclear Medicine, vol. 58, no. 1, pp. 85-90. https://doi.org/10.2967/jnumed.116.183194

German Multicenter Study Investigating Lu ¹⁷⁷-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients. / Rahbar, Kambiz; Ahmadzadehfar, Hojjat; Kratochwil, Clemens; Haberkorn, Uwe; Schaefers, Michael; Essler, Markus; Baum, Richard P.; Kulkarni, Harshad R.; Schmidt, Matthias; Drzezga, Alexander; Bartenstein, Peter; Pfestroff, Andreas; Luster, Markus; Luetzen, Ulf; Marx, Marlies; Prasad, Vikas; Brenner, Winfried; Heinzel, Alexander; Mottaghy, Felix M.; Ruf, Juri; Meyer, Philipp Tobias; Heuschkel, Martin; Eveslage, Maria; Boegemann, Martin; Fendler, Wolfgang Peter; Krause, Bernd Joachim.

In: Journal of Nuclear Medicine, Vol. 58, No. 1, 01.2017, p. 85-90.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - German Multicenter Study Investigating Lu 177-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

AU - Rahbar, Kambiz

AU - Ahmadzadehfar, Hojjat

AU - Kratochwil, Clemens

AU - Haberkorn, Uwe

AU - Schaefers, Michael

AU - Essler, Markus

AU - Baum, Richard P.

AU - Kulkarni, Harshad R.

AU - Schmidt, Matthias

AU - Drzezga, Alexander

AU - Bartenstein, Peter

AU - Pfestroff, Andreas

AU - Luster, Markus

AU - Luetzen, Ulf

AU - Marx, Marlies

AU - Prasad, Vikas

AU - Brenner, Winfried

AU - Heinzel, Alexander

AU - Mottaghy, Felix M.

AU - Ruf, Juri

AU - Meyer, Philipp Tobias

AU - Heuschkel, Martin

AU - Eveslage, Maria

AU - Boegemann, Martin

AU - Fendler, Wolfgang Peter

AU - Krause, Bernd Joachim

PY - 2017/1

Y1 - 2017/1

KW - prostate cancer

KW - PSMA-617

KW - mCRPC

KW - radioligand therapy

KW - GA-68-PSMA LIGAND

KW - CLINICAL-TRIALS

KW - PSMA

KW - ENZALUTAMIDE

KW - ABIRATERONE

KW - STATISTICS

KW - DOCETAXEL

KW - PET/CT

U2 - 10.2967/jnumed.116.183194

DO - 10.2967/jnumed.116.183194

M3 - Article

VL - 58

SP - 85

EP - 90

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 1

ER -